Achilles pain that has dragged on for months — a stiff, aching, sometimes swollen tendon at the back of your heel or lower calf that flares with activity and stiffens after rest — is one of the more frustrating overuse problems, partly because the instinct to simply rest it tends to backfire. Here is what is actually going on in the tendon, the treatment that helps most people, and an honest look at what comes next when it doesn't.
Why chronic Achilles pain behaves the way it does
Long-standing Achilles pain is usually tendinopathy, not "tendinitis" in the classic inflammatory sense. Under the microscope, a chronically painful Achilles shows degenerative changes — disorganized collagen fibers and a stalled repair response — rather than the hallmarks of straightforward acute inflammation. That distinction explains a lot of the frustration: because the problem is a failure of the tendon to remodel and strengthen, prolonged rest does not fix it and can leave the tendon weaker and more vulnerable when you return to activity.
Chronic painful tendons also develop a feature you cannot feel but that matters: neovascularization, an ingrowth of abnormal small blood vessels into the damaged area. These new vessels appear in painful tendons but not in normal, pain-free ones, and they are accompanied by new nerve fibers — which is why they are thought to contribute to the persistent pain (neovascularisation in Achilles tendons with painful tendinosis, PubMed). Keep that detail in mind; it matters for the newest treatment option.
The treatment that works for most people
The best-supported first-line treatment is not rest — it is loading. Progressive, heavy-load calf exercise (the eccentric heel-drop program is the classic version) is the cornerstone of managing chronic midportion Achilles tendinopathy, and it has the strongest evidence of any conservative treatment (eccentric exercise for mid-portion Achilles tendinopathy meta-analysis, PMC). Controlled loading stimulates the tendon to reorganize and rebuild, addressing the underlying degeneration rather than just quieting symptoms.
The single most important thing to know about this program is that it takes time and consistency. Meaningful improvement often requires 12 weeks or longer of daily, supervised loading, and many people who conclude "it isn't working" simply have not given it enough committed time (conservative management of Achilles tendinopathy, current clinical concepts, PMC). Other measures — activity modification, footwear or heel lifts, and physical therapy — support the loading program, but the loading is what does the heavy lifting.
A note on what to skip: anti-inflammatory medications offer little long-term benefit for the underlying tendon problem, and corticosteroid injections into the Achilles are generally avoided because of the risk of weakening the tendon. Give a proper loading program a genuine, months-long trial before concluding it has failed.
It also helps to know where your pain sits, because it changes how rehab is applied. Midportion tendinopathy — pain a few centimeters above the heel bone, in the substance of the tendon — is the form with the strongest evidence behind loading programs. Insertional tendinopathy, where the tendon meets the heel bone, tends to be more sensitive to positions that stretch the tendon over the bone, so the loading program is usually modified to avoid deep dorsiflexion. This is one reason a supervised program often works better than following a generic protocol from a video: the details of how you load, not just that you load, influence how well you respond.
An emerging option for pain that won't respond
For the minority of people whose Achilles pain persists despite months of committed rehab, the abnormal blood vessels described earlier become an appealing target — and that is the basis for an emerging, minimally invasive approach.
Transcatheter arterial embolization uses a catheter passed through a pinhole access to reach the abnormal vessels feeding the chronically painful tendon and reduce that abnormal blood flow, with the aim of quieting the accompanying pain-carrying nerves. It is done as an outpatient procedure. Early results are encouraging: a pilot study in patients with chronic Achilles tendinopathy refractory to conservative care reported the procedure was technically successful and significantly reduced pain (clinical outcomes of transarterial embolization for chronic Achilles tendinopathy pilot study, JVIR), and a systematic review of embolization across refractory tendinopathies found meaningful pain reduction with a good safety profile (transcatheter arterial tendinopathy embolization systematic review and meta-analysis, PubMed).
Here is the straight talk that matters for a decision like this: the evidence is still early. It comes from small pilot studies and pooled analyses, not large randomized controlled trials, so we do not yet have high-quality confirmation of how well it works or exactly who benefits most. This is a genuinely promising, minimally invasive option for stubborn Achilles pain — but it is one to weigh carefully with a clear picture of the current evidence, not a replacement for a proper loading program.
Putting it together
For chronic Achilles pain, the sequence is clear and honest: commit to progressive loading first and give it real time, because that resolves most cases. If pain persists despite that effort, that is exactly the situation where a minimally invasive, outpatient option — discussed candidly, evidence and uncertainties included — is worth exploring.
If Achilles pain has outlasted months of good rehab, our 2-minute foot assessment is a plain-language place to start, and you can explore the outpatient foot treatments we offer in more detail.
